Editor: What To Know
- He stayed an additional year at Harefield Hospital to complete a fellowship in cardiothoracic anesthesia and gained some experience in the management of complex cardiac surgeries, ventricular assist devices, and heart and lung transplant.
- Inspira Technologies is a very dynamic company specializing in extracorporeal respiratory system innovation, and I believe it can change the paradigm of treatment of the most severe patients suffering from acute respiratory failure.
- The Royal Brompton ECMO service is one of the largest in Europe and has been recognized as a center of excellence.
Dr. Stephane Ledot, a world-renowned expert in critical care and anesthesia, has joined Inspira Technologies’ Scientific Advisory Board.
Dr. Ledot is an expert in various clinical fields including Critical Care Medicine, Anesthesia, Extracorporeal Support, and Echocardiography. During his career, he has undertaken a large number of educational duties, including advanced cardiovascular life support (ACLS) instruction, critical care module for physiotherapists instruction, critical care module nursing school instruction, among others. Dr. Ledot is a highly appreciated speaker in the critical care space.
Dr. Stephane Ledot, “It is a real honor to be part of this very exciting journey. Inspira Technologies is a very dynamic company specializing in extracorporeal respiratory system innovation, and I believe it can change the paradigm of treatment of the most severe patients suffering from acute respiratory failure. I am convinced we will see new developments and applications of this technology that will translate into a better outcome for many patients.”
Dr. Ledot received his medical academic education at University Pierre et Marie Curie in Paris, France. His specialization in anesthetics and intensive care was obtained at the university de la Mediterranean in Marseille, France.
In August 2013, Dr. Ledot joined an extracorporeal life support fellowship at the National Health Services, in the United Kingdom. During that time, he was involved in the management and retrieval of patients with severe acute respiratory failure needing extracorporeal support. He stayed an additional year at Harefield Hospital to complete a fellowship in cardiothoracic anesthesia and gained some experience in the management of complex cardiac surgeries, ventricular assist devices, and heart and lung transplant.
Dr. Ledot has completed his accreditation for transesophageal echocardiography (TOE) from the European Association of Cardiovascular Imaging and holds a European Diploma in Intensive Care.
In the last few years, Dr. Ledot has served as a senior clinician in critical care and anesthetics at Royal Brompton & Harefield hospitals and became the director of the extracorporeal membrane oxygenation (ECMO) service and critical care. The Royal Brompton ECMO service is one of the largest in Europe and has been recognized as a center of excellence.
Dagi Ben-Noon, Inspira Technologies’ Chief Executive Officer, commented, “We welcome Dr. Ledot to Inspira Technologies’ Scientific Advisory Board. Dr. Ledot has valuable experience in intensive care medicine. We believe that Dr. Ledot can significantly contribute to our future efforts to introduce our innovative early extracorporeal respiratory support system, the ART device, to the international medical community.”
